Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia-Reference-Cited by-同舟云学术

Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia

Published:2016-10 Issue:4 Volume:215 Page:471.e1-471.e9
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Lakkaraja Madhavi,Berkowitz Richard L.,Vinograd Cheryl A.,Manotas Karen C.,Jin Jenny C.,Ferd Polina,Gabor Julia^ORCID,Wissert Megan^ORCID,McFarland Janice G.,Bussel James B.

Funder

Children's Cancer and Blood Foundation

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference26 articles.

1. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management;Peterson;Br J Haematol,2013

2. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia;Kjeldsen-Kragh;Blood,2007

3. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group;Dreyfus;Blood,1997

4. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia;Bussel;Pediatr Blood Cancer,2005

5. HPA-5b (Br[a]) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases;Kaplan;Br J Haematol,1991

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does anti‐HPA‐1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?;Pediatric Blood & Cancer;2024-01-11

2. Fetal and neonatal alloimmune thrombocytopenia: A rare case report of prenatal treatment;Clinical Case Reports;2023-08

3. Fetal and neonatal alloimmune thrombocytopenia in 2022;American Journal of Obstetrics and Gynecology;2023-06

4. Immune-Mediated Neonatal Thrombocytopenia;NeoReviews;2022-07-01

5. Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment;Haematologica;2022-06-16